Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Impedimed Limited ( (AU:IPD) ) has issued an update.
Impedimed Limited announced a change in the director’s interest, with Mr. Andrew Grant acquiring additional shares. The acquisition was a result of the issuance of shares in lieu of 30% of director fees for the quarter ended 31 December 2024, enhancing his total shareholding to 2,308,583 ordinary shares. This move signals a deeper alignment of the director’s interests with the company, potentially impacting stakeholder confidence positively.
More about Impedimed Limited
Impedimed Limited is a company involved in the medical technology industry, primarily focused on developing and providing non-invasive medical devices for measuring, monitoring, and managing fluid status and body composition.
YTD Price Performance: -2.50%
Average Trading Volume: 31,879
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $69.19M
For an in-depth examination of IPD stock, go to TipRanks’ Stock Analysis page.
